- (PLX AI) - Stillfront fell 4.5% despite earnings beating estimates on just about everything except organic growth, and analysts at Carnegie say it's a good buying opportunity.
- • Stillfront Q4 revenue, adj. EBITDA and adj. EBIT all came ahead of consensus
- • But organic growth was a decline of 5%, while some analysts expected only 4% decline
- • Negative organic growth is expected to continue in Q1, but for the full year 2022 Stillfront sees mid-single digit positive organic growth
- • With consensus estimate changes likely to be limited after this report, a negative share price reaction would be a good buying opportunity, Carnegie said
© 2022 PLX AI
